John C Gore Selected Research

Thomsen-Friedenreich antigen

1/2017	Evaluation of a novel fluorescent nanobeacon for targeted imaging of Thomsen-Friedenreich associated colorectal cancer.
3/2015	Fluorescence-based endoscopic imaging of Thomsen-Friedenreich antigen to improve early detection of colorectal cancer.
5/2013	Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.
11/2011	Essence of affinity and specificity of peanut agglutinin-immobilized fluorescent nanospheres with surface poly(N-vinylacetamide) chains for colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John C Gore Research Topics

Disease

50	Neoplasms (Cancer) 01/2024 - 04/2006
10	Breast Neoplasms (Breast Cancer) 05/2023 - 01/2007
9	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2008
7	Brain Neoplasms (Brain Tumor) 10/2022 - 09/2012
7	Fibrosis (Cirrhosis) 10/2022 - 11/2007
6	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
5	Colonic Neoplasms (Colon Cancer) 01/2020 - 10/2012
4	Glioma (Gliomas) 04/2019 - 04/2011
3	Amyloid Plaque 03/2024 - 01/2013
3	Ischemic Stroke 01/2018 - 04/2011
3	Stroke (Strokes) 10/2016 - 09/2012
2	Acidosis 01/2024 - 09/2012
2	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2012
2	Dementia (Dementias) 01/2023 - 12/2012
2	Acute Erythroblastic Leukemia (Erythroleukemia) 12/2022 - 01/2017
2	Necrosis 10/2022 - 04/2019
2	Kidney Diseases (Kidney Disease) 01/2021 - 04/2014
2	Infections 01/2018 - 06/2012
2	Insulin Resistance 06/2017 - 06/2015
2	Polyploidy 04/2017 - 01/2012
2	Polyps 01/2017 - 09/2008
2	Pain (Aches) 01/2017 - 05/2016
2	Calcinosis 03/2015 - 07/2014
2	Inflammation (Inflammations) 07/2014 - 01/2009
2	Liver Diseases (Liver Disease) 11/2008 - 09/2006
2	Hypoglycemia (Reactive Hypoglycemia) 02/2007 - 07/2006
1	Alkalosis 01/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Neuroinflammatory Diseases 12/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2023
1	Edema (Dropsy) 10/2022
1	Atrophy 10/2022
1	Schizophrenia (Dementia Praecox) 11/2021
1	Acute Kidney Injury (Acute Renal Failure) 07/2021
1	Pathologic Processes 10/2020
1	Contusions 01/2020
1	Relapsing-Remitting Multiple Sclerosis 01/2020
1	Cognitive Dysfunction 01/2020
1	Chronic Renal Insufficiency 11/2019
1	Ischemia 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2008
9	APTIBA 01/2018 - 09/2011
8	AmidesIBA 01/2021 - 09/2011
8	Protons (Proton)IBA 11/2019 - 09/2011
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2011
5	Amyloid (Amyloid Fibrils)IBA 03/2024 - 01/2013
5	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 07/2006
5	AntigensIBA 03/2015 - 05/2009
4	SaponinsIBA 12/2022 - 05/2016
4	Thomsen-Friedenreich antigenIBA 01/2017 - 11/2011
4	Peanut AgglutininIBA 01/2017 - 11/2011
4	Contrast MediaIBA 09/2012 - 11/2006
3	Polystyrenes (Polystyrene)IBA 01/2024 - 03/2015
3	C.I. direct red 80IBA 10/2022 - 12/2018
3	CollagenIBA 01/2021 - 12/2018
3	poly(N-vinylacetamide)IBA 07/2015 - 11/2011
2	Durapatite (Hydroxylapatite)IBA 01/2024 - 07/2014
2	Cetuximab (Erbitux)FDA Link 01/2019 - 11/2008
2	SodiumIBA 10/2017 - 06/2017
2	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 04/2017 - 01/2012
2	AerosolsIBA 01/2017 - 01/2015
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 05/2016
2	CurcuminIBA 01/2017 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 06/2015 - 07/2006
2	SugarsIBA 03/2015 - 11/2011
2	CalciumIBA 03/2015 - 07/2014
2	coumarin 6IBA 03/2015 - 03/2011
2	azuleneIBA 01/2012 - 01/2009
2	alovudineIBA 07/2009 - 11/2008
2	Caspase 3 (Caspase-3)IBA 07/2009 - 11/2008
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2009 - 11/2007
2	ManganeseIBA 11/2008 - 05/2008
1	SolutionsIBA 01/2024
1	CationsIBA 01/2024
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2023
1	Therapeutic UsesIBA 05/2023
1	tau Proteins (tau Protein)IBA 01/2023
1	ParaffinIBA 10/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	LigandsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2020
1	Coloring Agents (Dyes)IBA 12/2018
1	Iohexol (Omnipaque)FDA Link 01/2018

Therapy/Procedure

18	Therapeutics 01/2024 - 01/2009
6	Drug Therapy (Chemotherapy) 05/2023 - 01/2007
5	Neoadjuvant Therapy 01/2020 - 01/2007
4	Nanospheres 07/2015 - 03/2011
3	Injections 01/2024 - 11/2007
2	Immunotherapy 01/2024 - 01/2020
2	Radiotherapy 10/2022 - 04/2019
2	Lasers (Laser) 04/2014 - 06/2012
2	Parenteral Nutrition 11/2008 - 09/2006
1	Intravenous Injections 01/2018